Board of Directors
Executive Directors
-
Mr. Wang Chuang (Chairman, chief executive officer and executive director)
View all Details
Mr. Wang Chuang, joined the Group on 18 October 2019 as the Chairman, chief executive officer and executive director of the Company. Mr. Wang has been primarily responsible for overall operation and management, strategic planning and business development.
Mr. Wang was a senior executive of Changzhou Meichen Company Limited* (常州美晨有限公司), Wuxi Shencai Company Limited* (無錫神采有限公司) and Jiangsu Zhenai Company Limited* (江蘇真愛有限公 司) between 2002 and 2008.
He was the chairman of Hong Kong Bomei (China) Company Limited* (香港博美中國分公司) between 2008 and 2019. From 2015 to 2019, he acted as the chief executive officer of Changzhou XingKong Medical Clinic Co., Ltd.* (常州市星空醫療美容門診有限公司) and the chairman of Jiangsu XingKong Health Management Consulting Co., Ltd.* (江蘇星空健康管理諮詢有限公司). He is a committee member of the Organization Committee of the 2017 Boao Forum for Biomedical Sciences *(2017博鰲生物醫學論壇組織委員會) and the founder of Bomei Angel Charity Fund* (博美天使慈善基金). Mr. Wang is the president of the Chamber of Commerce of Changzhou Lishui* (常州溧水商會會長) and the vice president of the China’s National Alliance for Maternal and Child Health Development* (全國婦幼健康促進發展聯盟).
Mr. Wang Chuang was accredited as a grade 1 health management professional and a psychological consultant by the Hubei Provincial Department of Human Resources and Social Security of China and the Ministry of Human Resources and Social Security of China in May 2016 and March 2019.
Non-executive Directors
-
Mr. Tsang Ho Yin
View all Details
Mr. Tsang Ho Yin, was appointed as a non-executive Director of the Company. Mr. Tsang is currently a partner of Stevenson, Wong & Co., specialising in corporate finance and commercial law. He has extensive experience in legal fields.Mr. Tsang obtained a bachelor in laws degree and a bachelor in commerce (accounting) degree, both from the University of Melbourne, Australia in August 2008. Mr. Tsang obtained a master in laws degree from the University of Melbourne, Australia in August 2010. Mr. Tsang obtained the postgraduate certificate in laws from the City University of Hong Kong in July 2011. Mr. Tsang was admitted as a solicitor in Australia and Hong Kong in May 2012 and December 2013, respectively.
Since May 2019, Mr. Tsang has been the company secretary of Mabpharm Limited, a company listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) (stock code: 2181). As a company secretary. Since November 2019, Mr. Tsang has been the joint company secretary and authorised representative of Sunshine 100 China Holdings Ltd, a company listed on the Main Board of the Stock Exchange (stock code: 2608). Since January 2021, Mr. Tsang has been operated as the joint company secretory of Sundy Service Group Co., Ltd, a company listed on the Main Board of the Stock Exchange (stock code: 9608). Since September 2021, Mr. Tsang has been appointed as an independent non-executive Director of CROSSTEC Group Holdings Limited, a company listed on the Main Board of the Stock Exchange (stock code: 3893). Since September 2021, Mr. Tsang has been appointed as an independent non-executive Director of Sterling Group Holdings Limited, a company listed on the Main Board of the Stock Exchange (stock code: 1825).
From June 2019 to June 2020, Mr. Tsang was an independent non-executive director of Inno-Tech Holdings Limited (“InnoTech”) (a company which shares were listed on GEM of the Stock Exchange and delisted on 13 July 2021, stock code: 8202). InnoTech was a company incorporated in Bermuda with limited liability and its principal activities were (i) provision of outdoor advertising business through different advertising media network; (ii) television advertising operation; (iii) the event management business; (iv) seafood business; and (v) money lending business in Hong Kong. As disclosed in the announcements of Inno-Tech dated 1 June 2020, 3 July 2020 and 11 September 2020, Inno-Tech received a letter from the Official Receiver’s Officer dated 9 June 2020 which stated that Gram Capital Limited has filed a winding-up petition to the High Court of the Government of the Hong Kong Special Administrative Region against Inno-Tech for principal sum of HK$195,000. On 9 September 2020, Inno-Tech was ordered to be wound up by the High Court of Hong Kong Special Administrative Region in HCCW 82/2020 and the Official Receiver was appointed as the provisional liquidator. Mr. Tsang confirmed that he was not a party to such winding up petition and is not aware of any actual or potential claim that has been or will be made against him as a result thereof.
Independent Non-executive Directors
-
Dr. Liu Ming
View all Details
Dr. Liu Ming, joined the Group and was appointed as an independent non-executive Director on 30 December 2021. Dr. Liu graduated from the West China School of Medicine, West China Hospital of Sichuan University in 1991 with a Doctor of Medicine degree. He served in the Department of Otorhinolaryngology, Shenzhen People’s Hospital (Level A) (the “Hospital”) from 1991 to 2016 and served as the head of the Department of Otorhinolaryngology of the Hospital since 1998. He has been served as Deputy Director of the Hospital since 2006. He is currently a special expert of the Hospital in the Department of Otolaryngology. He has more than 25 years of medical clinical and hospital management experience.
Dr. Liu has been serving as executive director and a manager of Shenzhen Jianda Information Technology Limited since 2018, which is mainly engaged in the development and application of sleep breathing monitoring products. Dr. Liu has previously served as a general manager of a subsidiary of the Company since May 2018 and resigned from that position in August 2019.
Dr. Liu holds several community positions including the Standing Director of the Seventh Committee of the Shenzhen Medical Association, the Standing Committee member of the China International Association for the Promotion of Health Care, and the Standing Committee member of the Sleep Medicine Branch of the Guangdong Association of Rehabilitation Medicine.
-
Ms. Huo Chunyu
View all Details
Ms. Huo Chunyu, joined the Group and was appointed as an independent non-executive Director of the Company on 30 January 2020. Ms. Huo obtained a bachelor degree from Hebei University of Economics and Business (河北經貿大學). She has over 20 years of commercial and professional experience with companies including the Industrial and Commercial Bank of China Hebei Branch (中國工商銀行河北省分行), Shijiazhuang Haowei Optoelectronic Thin Film Technology Co., Ltd (石家莊豪 威光電子薄膜技術有限公司) and Hebei Youyuan Certified Public Accountants (河北有源會計師事務所). Since September 2012, she has been a Partner of Ruihua Certified Public Accountants (瑞華會計師事務所).
-
Mr. Leung Man Fai
View all Details
Mr. Leung Man Fai, joined the Group and was appointed as an independent non-executive Director on 30 December 2021. Mr. Leung graduated from Manchester Polytechnic in the United Kingdom with a degree of Bachelor of Arts in Accounting and Finance awarded by the Council for National Academic Awards of the United Kingdom in July 1988. He also obtained a degree of Master of Commerce in Accounting from the University of New South Wales in May 1990.
Mr. Leung has been a member of the HKICPA since June 1991 and has approximately 30 years of working experience in accounting, corporate finance and corporate management.
Mr. Leung is a company secretary of MediNet Group Limited (stock code: 8161), a company listed on the GEM Board of the Stock Exchange since November 2015 and he was a company secretary of Creative Enterprise Holdings Limited (stock code: 3992) from May 2018 to September 2021, which has been delisted from the Stock Exchange from October 2021. Mr. Leung has been an independent non-executive Director of Vital Innovations Holdings Limited (stock code: 6133), a company listed on the Main Board of the Stock Exchange since 30 December 2020.
Senior Management
-
Mr. Khoo Wun Fat William (Company secretary and the Authorised Representative)
View all Details
Mr. Khoo has extensive experience in the legal industry especially in corporate finance matters relating to commercial laws, securities laws and listing rules. From July 2007 to April 2010, Mr. Khoo worked at P. C. Woo & Co. as a trainee and then as an assistant solicitor. From May 2010 to April 2011, Mr. Khoo worked at Charltons as an assistant solicitor. From April 2011 to March 2014, Mr. Khoo worked at DLA Piper Hong Kong as an associate. Mr. Khoo established Khoo & Co. in November 2014.
Apart from his legal profession, Mr. Khoo has been a member of the standing committee of the convocation of the City University of Hong Kong (the “Convocation”) since January 2010 and is currently the Chairman of the Convocation and a council member of the City University of Hong Kong. He is also currently a director of the Alumni Association of Raimondi College. From November 2017 to March 2020, Mr. Khoo was an independent non-executive director of Alpha Professional Holdings Limited (formerly known as Z-Obee Holdings Limited) (a company listed on the Main Board (stock code: 948)). From August 2018 to May 2021, Mr. Khoo was an independent non-executive director of Zhejiang New Century Hotel Management Co., Ltd (a company listed on the Main Board (stock code: 1158)). From September 2018 to December 2021, Mr. Khoo was an independent non-executive director of Fameglow Holdings Limited (a company listed on the GEM Board (stock code 8603)). Mr. Khoo obtained a Bachelor of Science from the Chinese University of Hong Kong in December 2003. He obtained a Bachelor of Laws in November 2006 and the Postgraduate Certificate in Laws in July 2007 from the City University of Hong Kong. He was admitted as a solicitor of Hong Kong in September 2009, and he is now qualified as a practising lawyer in the Guangdong-Hong Kong-Macao Greater Bay Area.